Clinical Trial Update: Shortening Treatment by Advancing Novel Drugs [Phase 3]

View source ↗

Summary

Phase 3 trial update on shortening treatment by advancing novel drugs for pulmonary tuberculosis, including drug-sensitive and multi-drug-resistant forms; compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant | Phase 3 | Status: COMPLETED | Results posted: 2019-03-26